» Articles » PMID: 15078475

Preoperative Assessment of Liver Function: a Comparison of 99mTc-Mebrofenin Scintigraphy with Indocyanine Green Clearance Test

Overview
Journal Liver Int
Specialty Gastroenterology
Date 2004 Apr 14
PMID 15078475
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aims: The indocyanine green (ICG) clearance test is the most frequently used test for preoperative assessment of liver parenchymal function but has its limitations. The aim of this study was to investigate the correlation between ICG clearance test and the liver uptake of 99-Technetium-labelled (99mTc)-Mebrofenin (99mTc-Mebrofenin) as measured with hepatobiliary scintigraphy.

Methods: Fifty-four patients were diagnosed as hepatocellular carcinoma (n=9), hilar tumours (n=20) and 25 patients with non-parenchymal tumours including colorectal metastasis (n=15) and miscellaneous tumours (n=10). One day prior to operation, hepatobiliary 99mTc-Mebrofenin scintigraphy was performed after intravenous injection of 85 MBq and the 15-min clearance rate of ICG (ICG-C15) was measured.

Results: The mean ICG-C15 was 86.86+/-1.19% (SEM). The mean 99mTc-Mebrofenin uptake rate was 12.87+/-0.52%/min. A significant correlation was obtained between 99mTc-Mebrofenin uptake rate by scintigraphy and ICG-C15 (r=0.73, P<0.0001). The mean clearance capacity of the right liver segments (79.83+/-1.63, range 47.75-95.97%) was larger than that of the left segments (20.24+/-1.55, range 6.51-52.51%).

Conclusion: 99mTc-Mebrofenin uptake rate as assessed by scintigraphy is an efficient method for determining liver function and correlates well with ICG clearance. At the same time, 99mTc-Mebrofenin scintigraphy provides information of segmental functional liver tissue, which is of additional use when planning liver resection.

Citing Articles

Effect of Sarcopenia on the Increase in Liver Volume and Function After Portal Vein Embolization.

Arntz P, Olthof P, Korenblik R, Heil J, Kazemier G, van Delden O Cardiovasc Intervent Radiol. 2024; 47(5):642-649.

PMID: 38416177 PMC: 11074030. DOI: 10.1007/s00270-024-03676-2.


Assessing regional hepatic function changes after hypertrophy induction by radioembolisation: comparison of gadoxetic acid-enhanced MRI and Tc-mebrofenin hepatobiliary scintigraphy.

Fabritius M, Garlipp B, Ocal O, Puhr-Westerheide D, Amthauer H, Geyer T Eur Radiol Exp. 2024; 8(1):15.

PMID: 38282160 PMC: 10822831. DOI: 10.1186/s41747-023-00409-x.


The Role of the Multiparametric MRI LiverMultiScan in the Quantitative Assessment of the Liver and Its Predicted Clinical Applications in Patients Undergoing Major Hepatic Resection for Colorectal Liver Metastasis.

Chouari T, Merali N, La Costa F, Santol J, Chapman S, Horton A Cancers (Basel). 2023; 15(19).

PMID: 37835557 PMC: 10571783. DOI: 10.3390/cancers15194863.


Pushing the Limits of Surgical Resection in Colorectal Liver Metastasis: How Far Can We Go?.

Calderon Novoa F, Ardiles V, De Santibanes E, Pekolj J, Goransky J, Mazza O Cancers (Basel). 2023; 15(7).

PMID: 37046774 PMC: 10093442. DOI: 10.3390/cancers15072113.


Prevention of post-hepatectomy liver failure after major resection of colorectal liver metastases: is hepato-biliary scintigraphy the optimal tool?.

Cusumano C, Deshayes E, Guiu B, De Meeus G, Carrere S, Bouillin A Ann Transl Med. 2023; 11(5):202.

PMID: 37007571 PMC: 10061460. DOI: 10.21037/atm-22-3665.